Background: Corneal neovascularization is a major cause of blindness worldwide. The objective of our research is to identify the role of membrane type 1 matrix metalloproteinase (MT1-MMP) and its proteolytic functions in corneal neovascularization. Our laboratory has found that MT1-MMP is present in the cornea and cleaves anti-angiogenic fragments which may regulate corneal neovascularization during corneal wound healing. Hypothesis: During corneal wounding, stromal fibroblasts generate membrane-type matrix metalloproteinase (MT1-MMP), which mediates corneal neovascularization (NV) by three mechanisms: breakdown of the extracellular matrix (ECM), degradation of corneal anti-angiogenic factors, and transcriptional up-regulation of vascular endothelial growth factor (VEGF).
Specific aims : A. MT1-MMP Distribution and Enzymatic Activity in Corneal Neovascularization. B. Evaluation of 1st Pathway of Corneal Angiogenesis: ECM Breakdown by Keratotocyte Membrane-Associated MT1-MMP. C. Evaluation of the 2nd Pathway of Corneal Angiogenesis: Keratocyte-derived MT1-MMP Degradation of Corneal Anti-angiogenic Factors. D. Evaluation of the 3rd Pathway of Corneal Angiogenesis: MT1-MMP-Induced Transcriptional Upregulation of VEGF in Stromal Keratocytes. Significance: Understanding the mechanisms that maintain corneal avascularity may allow us to prevent blindness caused by corneal neovascularization. The study of MT1-MMP in the cornea may provide valuable information about their possible clinical significance in corneal neovascularization and wound healing.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
2R01EY010101-11
Application #
6619208
Study Section
Special Emphasis Panel (ZRG1-VISA (01))
Program Officer
Fisher, Richard S
Project Start
1993-12-01
Project End
2008-07-31
Budget Start
2003-08-01
Budget End
2004-07-31
Support Year
11
Fiscal Year
2003
Total Cost
$418,500
Indirect Cost
Name
Schepens Eye Research Institute
Department
Type
DUNS #
073826000
City
Boston
State
MA
Country
United States
Zip Code
02114
Zhong, Wei; Montana, Mario; Santosa, Samuel M et al. (2018) Angiogenesis and lymphangiogenesis in corneal transplantation-A review. Surv Ophthalmol 63:453-479
Yamakawa, Michael; Doh, Susan J; Santosa, Samuel M et al. (2018) Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review. Med Res Rev 38:1769-1798
Han, Kyu-Yeon; Tran, Jennifer A; Chang, Jin-Hong et al. (2017) Potential role of corneal epithelial cell-derived exosomes in corneal wound healing and neovascularization. Sci Rep 7:40548
Zhong, Wei; Gao, Xinbo; Wang, Shuangyong et al. (2017) Prox1-GFP/Flt1-DsRed transgenic mice: an animal model for simultaneous live imaging of angiogenesis and lymphangiogenesis. Angiogenesis 20:581-598
Giri, Pushpanjali; Azar, Dimitri T (2017) Risk profiles of ectasia after keratorefractive surgery. Curr Opin Ophthalmol 28:337-342
Chang, Jin-Hong; Putra, Ilham; Huang, Yu-Hui et al. (2016) Limited versus total epithelial debridement ocular surface injury: Live fluorescence imaging of hemangiogenesis and lymphangiogenesis in Prox1-GFP/Flk1::Myr-mCherry mice. Biochim Biophys Acta 1860:2148-56
Han, Kyu-Yeon; Chang, Jin-Hong; Lee, Hyun et al. (2016) Proangiogenic Interactions of Vascular Endothelial MMP14 With VEGF Receptor 1 in VEGFA-Mediated Corneal Angiogenesis. Invest Ophthalmol Vis Sci 57:3313-22
Yang, Jessica F; Walia, Amit; Huang, Yu-hui et al. (2016) Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions. Surv Ophthalmol 61:272-96
Han, Kyu-Yeon; Chang, Michael; Ying, Hong-Yu et al. (2015) Selective Binding of Endostatin Peptide 4 to Recombinant VEGF Receptor 3 In Vitro. Protein Pept Lett 22:1025-30
Han, Kyu-Yeon; Dugas-Ford, Jennifer; Lee, Hyun et al. (2015) MMP14 Cleavage of VEGFR1 in the Cornea Leads to a VEGF-Trap Antiangiogenic Effect. Invest Ophthalmol Vis Sci 56:5450-6

Showing the most recent 10 out of 37 publications